Neurosequential Model of Therapeutics (NMT)

Hull Services: Canada’s Only Neurosequential Model of Therapeutics (NMT) Flagship Site

Following more than two years of intensive certification and thousands of personnel hours dedicated to master the core concepts and implement the Neurosequential Model of Therapeutics (NMT) in our clinical setting, Hull Services was invited to become a Flagship Site for the ChildTrauma Academy (CTA) in the Neurosequential Model of Therapeutics. Now Hull Services is ready to offer your organization training in this leading edge approach.

Based in Houston, Texas, CTA has created a network of partner organizations across the world certified in the use of the NMT as recognition of an ongoing relationship with the CTA and the continuing demonstration of the intention to engage in extensive internal and external NMT related training, supervision, consultation and community engagement activities.

For more information contact Dr. Emily Wang, t: 403-251-8090, e: ewang@hullservices.ca


What is NMT?

The Neurosequential Model of Therapeutics (NMT) is a developmentally sensitive, neurobiology-informed approach to clinical problem solving. NMT is not a specific therapeutic technique or intervention. It is an approach that integrates core principles of neurodevelopment and traumatology to inform work with children, families and the communities in which they live. The Neurosequential Approach has three key components – training/capacity building, assessment and then, the specific recommendations for the selection and sequencing of therapeutic, educational and enrichment activities that match the needs and strengths of the individual.